RG-6913

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameRG-6913
Drug Alias NameRG-6913RG6913
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A